Benzinga | Feb 12, 2021 06:01AM EST

Sanofi Offers Cash Buyout For Kiadis

* Sanofi SA (NASDAQ: SNY) has launched a takeover offer for Kiadis Pharma NV (OTC:KIADF) to represent an aggregate adjusted equity value of (euro)308 million. The takeover offer is priced at (euro)5.45 per share in cash.

* Kiadis' board said it supported the offer, as it felt Sanofi's infrastructure and capabilities would help develop Kiadis' pipeline of products.

* Kiadis' proprietary platform is based on allogeneic or 'off-the-shelf' NK cells from a healthy donor that seeks and identifies malignant cancer cells and has broad application across various tumor types.

* The transaction was announced in November last year.

* Price Action: SNY stock is down 0.8% at $47.31 in premarket on the last check Friday.